Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Sunitinib received FDA approval in January 2006 for the treatment of advanced Renal cell carcinoma (RCC), based on superiority to interferon‑alfa in metastatic Clear Cell Renal Cell Carcinoma (ccRCC) (1, 2)
In 2006, sunitinib also obtained conditional approval in Europe for metastatic Renal cell carcinoma (RCC), later converted to standard approval as additional data accumulated (2, 3). European reviews describe sunitinib as…